2-Bromo-6-methylpyridine | CAS:5315-25-3

We serve 2-Bromo-6-methylpyridine CAS:5315-25-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromo-6-methylpyridine

Chemical Name:2-Bromo-6-methylpyridine
CAS.NO:5315-25-3
Synonyms:2-Bromo-6-Methyl Pyridine; 2-brom-6-methylpyridin; 
2-methyl-6-bromopyridine; 6-Bromo-2-picoline; 2-Bromo-6-Methylpyridine;
Molecular Formula:C5H5BrN2
Molecular Weight:173.01100
 
Physical and Chemical Properties:
Density:1.512;
Boiling point:102-103oC;
Flash point:207oF;
Index of Refraction:1.562;
 
Specification:
Appearance:Colourless to yellow liquid
Purity(GC):≥99.0%
Moisture:≤0.5%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis
 



Contact us for information like 2-Bromo-6-methylpyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Bromo-6-Methylpyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Bromo-2-picoline Use and application,2-Bromo-6-Methylpyridine technical grade,usp/ep/jp grade.


Related News: The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.methyl 3-aminothiophene-2-carboxylate manufacturer “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.3-Chloro-2-fluoropyridine supplier “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.ethyl 2-amino-5-oxo-7-propan-2-ylchromeno[2,3-b]pyridine-3-carboxylate vendor The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.”So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.